Back
United Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
UTHR
United Therapeutics
Last Price:
$314.18
Seasonality Move:
3.89%
7 Day Trial
ALL ACCESS PASS
$
7

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 310.56 | Buy |
20-day SMA: | 329.3 | Sell |
50-day SMA: | 348.43 | Sell |
200-day SMA: | 344 | Sell |
8-day EMA: | 313.86 | Buy |
20-day EMA: | 324.68 | Sell |
50-day EMA: | 341.43 | Sell |
200-day EMA: | 334.25 | Sell |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.46 | Sell |
Relative Strength Index (14 RSI): | 41.1 | Sell |
Chaikin Money Flow: | -406517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (308.27 - 361.63) | Sell |
Bollinger Bands (100): | (336.95 - 381.89) | Sell |
United Therapeutics Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 314.12 while UTHR 8-day simple moving average is 310.56, which is a Buy signal.
-
The stock price of UTHR is 314.12 while United Therapeutics 20-day SMA is 329.30, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 348.43 while UTHR share price is 314.12, making it a Sell technically.
-
UTHR stock price is 314.12 and United Therapeutics 200-day simple moving average is 344.00, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $314.12. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
14.1B
Price in USD:
314.12
Share Volume:
418K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
221.53
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 314.12 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 314.12 while UTHR 8-day exponential moving average is 313.86, which is a Buy signal.
-
The stock price of UTHR is 314.12 while United Therapeutics 20-day EMA is 324.68, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 341.43 while UTHR share price is 314.12, making it a Sell technically.
-
UTHR stock price is 314.12 and United Therapeutics 200-day simple moving average is 334.25, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.65 per share, and an increase next year of $0.19 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -12.46, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 41.1, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (308.27 - 361.63), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (336.95 - 381.89), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.